COMMUNIQUÉS West-GlobeNewswire

Bradmer Pharmaceuticals Cancels Meeting of Subscription Receipt Holders
11/06/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. TORONTO, June 11, 2018 (GLOBE NEWSWIRE) -- Bradmer Pharmaceuticals Inc. (“ Bradmer ” or the “ Company ”) (TSX VENTURE:BMR.H) [...]
Tivity Health to Present at the William Blair 38th Annual Growth Stock Conference
11/06/2018
NASHVILLE, Tenn., June 11, 2018 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ:TVTY) will present at the William Blair 38 th Annual Growth Stock Conference to be held June 12-14, 2018, in Chicago. Donato Tramuto, [...]
Easton Pharmaceuticals Announces That Easton and Its JV Partner, Alliance Group, Have Generated $40,000 in Revenues in the First Week of Operations
11/06/2018
Operations are Anticipated to Continually Increase, Which Includes Volume and Pricing, While it Prepares to Launch Its More Profitable Aggregate Operations TORONTO, ON, June 11, 2018 (GLOBE NEWSWIRE) -- Easton [...]
BioRestorative Therapies Reports Positive Findings from Independent Review of its BRTX-100 Program
11/06/2018
MELVILLE, N.Y., June 11, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today reported the findings [...]
DRAFT RESOLUTIONS of Annual General Meeting of Shareholders of joint stock company “Grindeks” to be held on 26 June 2018
11/06/2018
Approved at the meeting of the Board of joint stock company “Grindeks” on 11 June 2018 and revised at the meeting of the Supervisory Council of joint stock company “Grindeks” on 11 June 2018 DRAFT RESOLUTIONS of Annual [...]
Aquinox Pharmaceuticals Announces Initiation of ProShip Phase 2 Proof-of-Concept Clinical Trial Investigating Rosiptor in CP/CPPS
11/06/2018
- Trial Will Enroll Approximately 100 Male Subjects in the US and Canada - VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (" Aquinox ") (NASDAQ:AQXP), a clinical-stage [...]
RECORDATI ACQUIRES NATURAL POINT S.R.L. IN ITALY
11/06/2018
Milan, 11 June 2018 - Recordati announces the acquisition of 100% of the share capital of Natural Point S.r.l., an Italian company, based in Milan, active in the food supplements market. The company realized sales of € [...]
Kansas University Medical Center and iSage Rx Receive Blue Cross and Blue Shield of Kansas City (Blue KC) Outcomes Grant to Study Insulin Optimization
11/06/2018
Insulin-Dependent Patients Will Be Enrolled in Clinical Trial Using iSage’s FDA Cleared Insulin Titration Application WILMINGTON, Del., June 11, 2018 (GLOBE NEWSWIRE) -- The University of Kansas Medical Center (KUMC), a [...]
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Analogic Shareholders Vote “For” Proposed Analogic Acquisition by Affiliate of Altaris Capital Partners
11/06/2018
Special Meeting of Shareholders To Be Held June 21, 2018 PEABODY, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (NASDAQ:ALOG) (“the Company” or “Analogic”), a provider of leading-edge healthcare and [...]
Advantis Corp. Expanding Into Two New Locations, As Demand Continues to Drive Further Production Capacity
11/06/2018
NEWPORT BEACH, CA, June 11, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) announced that it is in the process of securing a pair of industrial packaging locations in Los Angeles and Orange County, that [...]
Comprehensive Pharmacy Services Expands Telepharmacy Solutions
11/06/2018
CPS Telepharmacy’s New Innovation Center Built to Meet Growing Technology Demand MEMPHIS, Tenn., June 11, 2018 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services (CPS) announced today that it has enhanced and expanded [...]
TRHC’s SinfoníaRx named a “Top Company to Work for in Arizona” for Third Year in a Row
11/06/2018
MOORESTOWN, N.J., June 11, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ:TRHC), a healthcare technology company optimizing medication safety, announced today its subsidiary, SinfoníaRx, has earned [...]
VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent for Use of Stem Cells to Treat Cancer and Autoimmune Disorders
11/06/2018
Patent Covers Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ:VTGN), a clinical-stage [...]
70% of Canadian Men’s Chronic Health Conditions are Caused by Lifestyle, not Genetics
11/06/2018
Earlier detection of diabetes and cardiovascular issues with preventive action can reverse and prevent disease. UBC spin-off, Molecular You, offers a solution VANCOUVER, British Columbia, June 11, 2018 (GLOBE NEWSWIRE [...]
PositiveID to Exhibit its Caregiver Non-Contact Thermometer at the Association for Professionals in Infection Control and Epidemiology Annual Conference June 13-15th
11/06/2018
The rise in difficult-to-treat super bugs spread from skin-to-skin contact stresses the need for thermometers that do not touch the patient DELRAY BEACH, Fla., June 11, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“ [...]
Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
11/06/2018
SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]
The American Health Council Physician Board Welcomes Marvin Faulkner, DO, BA
11/06/2018
NEW YORK, June 11, 2018 (GLOBE NEWSWIRE) -- The American Health Council welcomes Marvin Faulkner, DO, BA to its Board of Physicians for his outstanding contributions to the medical field. As a pain physician at [...]
Paratek Presents New Analysis from Combined Phase 3 Skin Infection Studies Highlighting Efficacy of Omadacycline in Treating Drug Resistant S. aureus at ASM Microbe 2018
11/06/2018
BOSTON, June 11, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors
11/06/2018
NEWTON, Mass., June 11, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics [...]

Pages